-
Mashup Score: 3Certified Cardiovascular Knowledge Examination - For NPs/PAs practicing in the U.S. - American College of Cardiology - 5 hour(s) ago
Demonstrate your clinical knowledge and commitment to cardiovascular excellence by taking and passing ACC’s Certified Cardiovascular Knowledge Examination (CCKE). Open to NPs/PAs practicing in the U.S.
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 3Focus on Intervention | AHA2024: A Dive Into Key Trials - American College of Cardiology - 14 hour(s) ago
The American Heart Association (AHA) 2024 Scientific Sessions in Chicago provided a platform for sharing the latest advancements in interventional cardiology. Here we delve into some of the most significant trials presented, including some beyond interventional cardiology, exploring their implications for clinical practice and future research directions. By staying informed about the latest research findings, clinicians can optimize patient care and improve outcomes for individuals with cardiovascular
Source: www.acc.orgCategories: General Medicine News, CardiologistsTweet-
Delve into some of the most significant trials presented at #AHA24, including some beyond interventional cardiology, and explore their implications for clinical practice and future research directions. Read more: https://t.co/va9wxINbdt #CardiologyMag https://t.co/aNiBhS6umr
-
-
Mashup Score: 15Prioritizing Health | Ultra-Processed Foods: The Enemy in the Food System? - American College of Cardiology - 23 hour(s) ago
Poor dietary habits are a critical determinant of cardiovascular health and a major modifiable risk factor in the development of cardiovascular disease. 1,2 Plant-based, Mediterranean and Dietary Approaches to Stop Hypertension (DASH) diets have all demonstrated clear cardioprotective benefits in primary and secondary prevention. 3-6 However, the standard American diet remains largely low in fruits, vegetables, whole grains and lean protein, and high in ultra-processed foods (UPF). 7,8 The term ultra-proce
Source: www.acc.orgCategories: General Medicine News, CardiologistsTweet-
Hear from ACC’s Prevention of #CVD Section leaders as they delve into the topic of heart health and ultra-processed foods, with consideration of factors like #SDOH & #healthequity. More: https://t.co/MUU9eo1oe1 #ACCPrev #CardiologyMag https://t.co/0yIIqUYNly
-
-
Mashup Score: 13Heart Tank for the Cardiovascular Investigator – Heart Failure - American College of Cardiology - 1 day(s) ago
Join our distinguished panel of judges as they hear Young Investigators pitch their heart failure research ideas “Shark Tank” style. See which project has the most potential and learn from our judges the tools one needs to conduct successful research. The Heart Tank for the Cardiovascular Investigator presents a “Shark Tank” style competition where promising young researchers pitch their innovative Heart Failure research ideas to a panel of distinguished judges. This unique format offers a valuable
Source: www.acc.orgCategories: General Medicine News, CardiologistsTweet-
ACC Webinar: Heart Tank For the CV Investigator: HF Join a distinguished panel of judges on Wednesday, Feb. 26 at 7 p.m. ET as they hear young investigators pitch their #HeartFailure research ideas "Shark Tank" style. Learn more & register now: https://t.co/1pxjHgwbyt… https://t.co/WAw4hlHqSU https://t.co/hJJGAZurBo
-
-
Mashup Score: 5ACCEL Lite: SUMMIT Trial: Tirzepatide for Heart Failure, Preserved Ejection Fraction and Obesity - American College of Cardiology - 1 day(s) ago
The SUMMIT trial compared the safety and efficacy of tirzepatide among patients with heart failure with preserved ejection fraction (HFpEF) and obesity. Results from the trial concluded that treatment of obesity reduces major heart failure events in addition to improving health status and exercise tolerance. In this interview, Drs. Alison Bailey and Milton Packer examine the power of tirzepatide expanding beyond weight loss and treating diabetes in addition to reducing heart failure events in patients
Source: www.acc.orgCategories: General Medicine News, CardiologistsTweet-
#ACCEL Lite: SUMMIT Trial In this podcast, Drs. @a_l_bailey & Milton Packer examine the power of tirzepatide expanding beyond weight loss & treating diabetes in addition to reducing #HeartFailure events in patients w/ obesity-related #HFpEF. 🎧 https://t.co/Zo5FptJdeV #cvPrev https://t.co/HtPn1Haiq0
-
-
Mashup Score: 2Action Alerts - American College of Cardiology - 2 day(s) ago
With your help, ACC Advocacy actively works with Congress, state legislators, and other key decision makers to transform cardiovascular care and improve heart health. However, we need everyone’s voice at the table to make a difference for patients and health care professionals. The ACC offers a number of ways for its members to get involved in advocating for health policies that ensure continued patient access to quality, cost-effective care. Questions? Contact us at [email protected].
Source: www.acc.orgCategories: General Medicine News, CardiologistsTweet-
#ACCAdvocacy is working to keep the cardiovascular community at the forefront of lawmakers' minds. Want to join the effort? Urge Congress to advance immediate Medicare payment relief & permanent telehealth flexibilities with #ACCGrassroots. Take Action: https://t.co/7gVPU73afk
-
-
Mashup Score: 4EP SAP - American College of Cardiology - 2 day(s) ago
Learn more about the new version of EP SAP!
Source: www.acc.orgCategories: General Medicine News, CardiologistsTweet-
Take your electrophysiology knowledge to 🆕 heights with #EPSAP. Designed to cover the full scope of #cvEP, this program includes engaging lectures, hundreds of case-based practice questions, & more. Start learning today: https://t.co/XCLOB9Cq4t https://t.co/KXVVRTpD5H
-
-
Mashup Score: 13LAAO Registry: Racial Disparities in LAAO Use and Outcomes at 1 Year - American College of Cardiology - 2 day(s) ago
Among patients undergoing left atrial appendage occlusion (LAAO), rates of procedural success were similar across racial and ethnic groups, but Black patients had higher rates of death and bleeding at one year, according to a recent study published in the Journal of the American Heart Association. Oluseun O. Alli, MBBS, FACC, included a total of 97,185 patients (90% White, 3.9% Black, 2.9% Hispanic/Latinx) from the ACC’s LAAO Registry who underwent WATCHMAN FLX implantation through September 2022. They
Source: www.acc.orgCategories: General Medicine News, CardiologistsTweet-
Among patients undergoing left atrial appendage occlusion, rates of procedural success were similar across racial and ethnic groups, but Black patients had higher rates of death and bleeding at one year. Find out more: https://t.co/lozdVb06sN #LAAORegistry #NCDR
-
-
Mashup Score: 0FDA Update: Philips Corrects Monitoring Service Application For Mobile Cardiac Outpatient Telemetry - American College of Cardiology - 2 day(s) ago
The U.S. Food and Drug Administration (FDA) announced on Jan. 13 that Philips is correcting the Monitoring Service Application used with Mobile Cardiac Telemetry Monitoring as some electrocardiogram (ECG) events received by the application between July 2022 to July 2024 were not properly routed, which may have led to missing information or notifications. According to the agency, “Some of the ECG events received into the application during this time period met criteria to be escalated back to ordering
Source: www.acc.orgCategories: General Medicine News, CardiologistsTweet-
#FDAUpdate: @US_FDA announced that Philips is correcting the Monitoring Service Application used with Mobile Cardiac Telemetry Monitoring as some #ECG events received were not properly routed. Learn more ➡️ https://t.co/SxxKZ69eVg #ACCAdvocacy
-
-
Mashup Score: 168State-of-the-Art Review Examines LAAO as Therapy For Stroke Prevention in Patients With AFib - American College of Cardiology - 2 day(s) ago
The utility of left atrial appendage occlusion (LAAO) as a therapy for stroke prevention in patients with nonvalvular atrial fibrillation (AFib) is the focus of a State-of-the-Art Review published Jan. 8 in JACC: Clinical Electrophysiology. Jalaj Garg, MBBS, FACC, et al., discuss the procedure’s journey to becoming a mainstream approach for stroke prevention, advancements in LAAO devices over the past two decades, and domains requiring additional scientific inquiry. The authors describe the LAA as an
Source: www.acc.orgCategories: General Medicine News, CardiologistsTweet-
The utility of left atrial appendage occlusion as a therapy for stroke prevention in patients with nonvalvular #AFib is the focus of a State-of-the-Art Review published in #JACCCEP. Read more: https://t.co/wr1G6KgLPN https://t.co/9P5QY5l4UW
-
ACC's CCKE for NPs/PAs allows participants to demonstrate their clinical knowledge, commitment to CV excellence & grow their professional accomplishments. The first testing window will take place Nov. 16-19! Encourage your team to apply today: https://t.co/oisaPPEII9 https://t.co/EO61hUrLvp